On Friday, Corvus Pharmaceuticals Inc (CRVS) stock saw a modest uptick, ending the day at $7.21 which represents no change from the prior close of of $7.21. The stock opened at $7.11 and touched a low ...
StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a ...
Scotiabank started coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research note issued to ...
Fintel on MSN19h
Cantor Fitzgerald Downgrades Lilium N.V. (LILM)Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...
Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...
Cantor Fitzgerald analyst Andres Sheppard initiates coverage on PureCycle Technologies, Inc. (NASDAQ:PCT) with an Overweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback